Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old ...
The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback